2020
Non-Alcoholic Fatty Liver Disease Modifies Serum Gamma-Glutamyl Transferase in Cigarette Smokers
Oni ET, Figueredo V, Aneni E, Veladar E, McEvoy JW, Blaha MJ, Blumenthal RS, Conceicao RD, Carvalho JAM, Santos RD, Nasir K. Non-Alcoholic Fatty Liver Disease Modifies Serum Gamma-Glutamyl Transferase in Cigarette Smokers. Journal Of Clinical Medicine Research 2020, 12: 472-482. PMID: 32849935, PMCID: PMC7430878, DOI: 10.14740/jocmr3932.Peer-Reviewed Original ResearchNon-alcoholic fatty liver diseaseGamma-glutamyl transferaseSerum gamma-glutamyl transferaseClinical cardiovascular diseaseHigh GGT levelsGGT levelsNAFLD statusOxidative stressAbsence of NAFLDPresence of NAFLDPrevalence of NAFLDFatty liver diseaseImpact of smokingCross-sectional associationsCV riskCardiovascular riskCurrent smokersCurrent smokingMultivariable adjustmentLiver diseaseCigarette smokersEffect modificationCardiovascular diseaseHealthy subjectsSmoking
2014
Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
Jamal O, Aneni EC, Shaharyar S, Ali SS, Parris D, McEvoy JW, Veledar E, Blaha MJ, Blumenthal RS, Agatston AS, Conceição RD, Feldman T, Carvalho JA, Santos RD, Nasir K. Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome. Diabetology & Metabolic Syndrome 2014, 6: 79. PMID: 25960769, PMCID: PMC4424791, DOI: 10.1186/1758-5996-6-79.Peer-Reviewed Original ResearchHs-CRPSystemic inflammationCigarette smokingMetabolic syndromeHigh-sensitivity C-reactive proteinCardiovascular disease riskCombination of smokingC-reactive proteinLogistic regression modelsBackgroundEmerging dataSmoking statusSmoking cessationReactive proteinEntire populationSmokersSmokingInflammationDisease riskBrazilian subjectsMetSRegression analysisSignificant increaseSyndromeRiskAdditive effect